Accepted at 1:38 p.m. Feb, 16, 2025 by jollydolphin
Author: jollydolphin
Related Note: 1509215835845
Rationale for change

Apply standard ambiguous pluralization in question

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::06_Cytarabine #AK_Step1_v12::#OME_banner #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Nucleoside_Analogs::Cytarabine #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Other::Only_Step_1 #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#SketchyBiochem::03_Molecular_Biology::01_DNA::02_DNA_Replication_(Prokaryotes_&_Eukaryotes) #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::03_Cytotoxic_Nucleoside_Analogs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::01_Acute_Myeloid_Leukemia